MedPath

Diabetes Exercise and Lifestyle Trial

Early Phase 1
Conditions
Diabetes Mellitus
Interventions
Behavioral: High volume combined aerobic/resistance exercise
Behavioral: Low volume combined aerobic/resistance exercise
Behavioral: High volume combined A/R exercise, printouts, pedometers
Behavioral: Low volume combined A/R exercise, printouts, pedometers
Behavioral: Printed PA information, pedometers and step log group
Behavioral: Control
Registration Number
NCT00877864
Lead Sponsor
University of Calgary
Brief Summary

The objective of this study is to determine the effects of supervised combined aerobic and resistance training, and the effects of stage-matched written materials delivered by mail or internet, alone or in combination, on glycemic control as reflected in A1C (glycated hemoglobin).

Detailed Description

Background Rationale: Structured, supervised exercise programs involving aerobic exercise, resistance exercise or their combination resulted in significant improvements in glycemic control in type 2 diabetes. It has also been shown that programs which include a psychological/behavioral component in addition to diet and exercise have been most effective for long-term treatment of obesity in diabetes. The supervised exercise program has stronger evidence for improvement of metabolic control and cardiac risk, but its longer-term sustainability has not been demonstrated, and it is relatively costly. A stage-matched printed materials/pedometer intervention has been shown to increase physical activity over a longer period of time, and likely at a lower per-patient cost than the supervised exercise intervention, but with less evidence for improvement of metabolic control.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
26
Inclusion Criteria
  • type 2 diabetes
  • A1c 0.700-0.099
  • ability to read and write English
  • signed ICF
Exclusion Criteria
  • participation in previous 6 months in exercise > 2 times per week for at least 20 min per session
  • insulin therapy changes in medication for diabetes, BP or Lipids

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
High volume combined aerobic/resistance exerciseHigh volume combined aerobic/resistance exercise-
Low volume combined aerobic/resistance exerciseLow volume combined aerobic/resistance exerciseLow volume combined aerobic/resistance exercise
High volume combined A/R exercise, printouts, pedometersHigh volume combined A/R exercise, printouts, pedometersHigh volume combined aerobic/resistance exercise, printouts, pedometers
Low volume combined A/R exercise, printouts, pedometersLow volume combined A/R exercise, printouts, pedometersLow volume combined aerobic/resistance exercise, printouts, pedometers
Printed PA information, pedometers and step log groupPrinted PA information, pedometers and step log groupPrinted physical activity information, pedometers and step log group
ControlControl-
Primary Outcome Measures
NameTimeMethod
The primary outcome will be A1c at the end of 6 months supervised exercise period.6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Calgary

🇨🇦

Calgary, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath